The estimated Net Worth of Nicholas Stewart Green is at least $4.11 Milion dollars as of 9 July 2024. Mr Green owns over 14,400 units of Avid Bioservices Inc stock worth over $2,331,693 and over the last 4 years he sold CDMO stock worth over $233,479. In addition, he makes $1,545,522 as Pres i CEO & Director at Avid Bioservices Inc.
Mr has made over 19 trades of the Avid Bioservices Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 14,400 units of CDMO stock worth $152,640 on 9 July 2024.
The largest trade he's ever made was exercising 77,392 units of Avid Bioservices Inc stock on 28 June 2023 worth over $820,355. On average, Mr trades about 14,799 units every 38 days since 2020. As of 9 July 2024 he still owns at least 219,971 units of Avid Bioservices Inc stock.
You can see the complete history of Mr Green stock trades at the bottom of the page.
Nicholas Stewart Green B.Sc., MBA is the Pres, CEO & Director at Avid Bioservices Inc.
As the Pres i CEO & Director of Avid Bioservices Inc, the total compensation of Mr MBA at Avid Bioservices Inc is $1,545,522. There are no executives at Avid Bioservices Inc getting paid more.
Mr MBA is 56, he's been the Pres i CEO & Director of Avid Bioservices Inc since . There are 6 older and 5 younger executives at Avid Bioservices Inc. The oldest executive at Avid Bioservices Inc is Joseph Carleone, 74, who is the Independent Non-Executive Chairman of the Board.
Nicholas's mailing address filed with the SEC is 14191, Myford Road, Walnut, Tustin, Orange County, California, 92780, United States.
Over the last 7 years, insiders at Avid Bioservices Inc have traded over $1,839,814 worth of Avid Bioservices Inc stock and bought 460,748 units worth $3,573,760 . The most active insiders traders include Gregory Sargen, Nicholas Stewart Green oraz Mark R Bamforth. On average, Avid Bioservices Inc executives and independent directors trade stock every 16 days with the average trade being worth of $107,028. The most recent stock trade was executed by Richard A. Richieri on 12 July 2024, trading 1,469 units of CDMO stock currently worth $15,571.
avid bioservices, a subsidiary of peregrine pharmaceuticals, inc. (nasdaq: pphm), is a unique contract manufacturing organization ("cmo") partner dedicated to the development and production of monoclonal antibodies, recombinant proteins and enzymes produced in mammalian cell culture. our extensive experience at all stages of development enables us to provide comprehensive development, manufacturing and support services to navigate a biologic from concept to commercialization.
Avid Bioservices Inc executives and other stock owners filed with the SEC include: